Whalegun
Home

Travere Therapeutics TVTX spent $140K on lobbying in Q2 2026 · Health Issues, Pharmacy and 4 more issues

Trade details

Type
Lobbying report
Amount
$140,000
Quarter
Q2 2026
Stock
Travere Therapeutics TVTX
Client
Travere Therapeutics
Reported
26/07/20

Down 30.0% from last quarter

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Travere Therapeutics's other lobbying reports

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $16K

    Reported 08/04

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $70K

    Reported 07/20

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $16K

    Reported 05/19

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $80K

    Reported 04/20

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $200K

    Reported 04/20